Skip to content

Vincristine sulfate

Marqibo, Oncovin (vincristine sulfate) is a small molecule pharmaceutical. Vincristine sulfate was first approved as Marqibo on 1982-01-01. It is used to treat hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, and rhabdomyosarcoma amongst others in the USA. The pharmaceutical is active against tubulin beta chain.
Trade Name Marqibo, Oncovin
Common Name Vincristine sulfate
Indication hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, rhabdomyosarcoma, wilms tumor
Drug Class Vinca alkaloids
Vincristine sulfate
Get full access now